{"id":496393,"date":"2025-01-23T14:43:27","date_gmt":"2025-01-23T09:13:27","guid":{"rendered":"https:\/\/inc42.com\/?p=496393"},"modified":"2025-01-23T15:44:43","modified_gmt":"2025-01-23T10:14:43","slug":"kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr","status":"publish","type":"post","link":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/","title":{"rendered":"Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr"},"content":{"rendered":"

Kotal Alternate Asset Managers (Kotak Alt), has made the first close of its life sciences fund at INR 250 Cr (around $29 Mn).<\/p>\n

The fund, with a target corpus of INR 1,600 Cr (around $185 Mn), has seen participation from family offices, UHNIs (ultra high net worth individuals), industry veterans and other institutions.<\/p>\n

The fund will invest in early to growth stage startups operating in the life sciences space which includes medical devices, digital health, consumer wellness, diagnostics and delivery, Kotak Alt said in a statement.<\/p>\n

In the past two years, the Kotak Mahindra Group\u2019s alternative assets management entity has invested a total of INR 4,000 Cr in the healthcare sector. Along with financial backing, it also aims to lend support to selected startups in differentiating themselves from other players in the market.<\/p>\n

\u201cLife sciences is a core sector where the firm deploys capital across the lifecycle of the company i.e. early, growth and late stage,\u201d said Ashish Ranjan, director private equity at Kotak Alt.<\/p>\n

Founded in 2005, Kotak Alt claims to have raised and managed a total of over $22 Bn across various asset classes such as private equity, real estate, infrastructure, special situations, private credit and investment advisory.<\/p>\n

In September last year, the investment firm backed D2C nutrition startup Nutrabay which raised $5 Mn<\/a> and also participated in the $5 Mn<\/a> Series A funding round of Biotech startup Ahammune Biosciences.<\/p>\n

Kotak Alt\u2019s healthcare and life sciences fund was incorporated in 2018 and till date it has made a total of 19 investments through that fund, according to its website.<\/p>\n

The development comes close on the heels of many venture capital firms marking close of their\u00a0 funds in the recent past.<\/p>\n

Two days back, Bharat Value Fund announced the first close of its third investment fund at INR 1,250 Cr with a target corpus of INR 2,500 <\/a>Cr to back resilient and asset backed businesses in multiple sectors.<\/p>\n

Early this week it was reported that Sify Technologies is aiming to invest $5 Bn <\/a>in India over a period of five years to build smaller AI inferencing facilities in 20 tier-II cities.<\/p>\n

Moreover, last week Cornerstone Ventures also announced the first close of its second fund, which has a target corpus of $200 Mn, at about $40 Mn<\/a> to back innovative B2B technology startups.<\/p>\n","protected":false},"excerpt":{"rendered":"

Kotal Alternate Asset Managers (Kotak Alt), has made the first close of its life sciences fund at INR 250 Cr…<\/p>\n","protected":false},"author":116473,"featured_media":496395,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"title":"Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr","image":"https:\/\/inc42.com\/cdn-cgi\/image\/quality=75\/https:\/\/asset.inc42.com\/2025\/01\/Riceberg-funding-1.png","author_url":"https:\/\/inc42.com\/author\/kartikay-kashyap\/","author_name":"Kartikay Kashyap","category":"News","tags":"Banking,Finance,Services,Spot News","twitter":"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.","facebook":"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.","linkedin":"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.","push_notification":"","newsletter_snippets":""},"categories":[15],"tags":[12616,11069,48746,215625],"structure_data":{"company_type":"Investors","author_name":"Kartikay Kashyap","parent_category":"News","second_category":null,"development_type":"Startup Funding & Investments","post_story_type":"Spot News","shelf_life":"3 Days","primary_company":"kotak-mahindra-bank","second_company":null,"primary_industry":null,"series":null,"bucket":"","sub_bucket":""},"acf":{"twitter":"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.","facebook":"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.","linkedin":"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.","push_notification":"","newsletter_snippets":"","sentiment__tonality":"Positive","dh_short_body":"","dh_short_cta":"Tap To Learn More","dh_image":""},"yoast_head":"\nKotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr<\/title>\n<meta name=\"description\" content=\"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr\" \/>\n<meta property=\"og:description\" content=\"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/inc42.com\/wp-json\/wp\/v2\/posts\/496393\/\" \/>\n<meta property=\"og:site_name\" content=\"Inc42 Media\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/Inc42\" \/>\n<meta property=\"og:image\" content=\"https:\/\/inc42.com\/cdn-cgi\/image\/quality=75\/https:\/\/asset.inc42.com\/2025\/01\/Riceberg-funding-2-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kartikay Kashyap\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr\" \/>\n<meta name=\"twitter:description\" content=\"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.\" \/>\n<meta name=\"twitter:creator\" content=\"@Inc42\" \/>\n<meta name=\"twitter:site\" content=\"@Inc42\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kartikay Kashyap\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr","description":"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/","og_locale":"en_US","og_type":"article","og_title":"Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr","og_description":"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.","og_url":"https:\/\/inc42.com\/wp-json\/wp\/v2\/posts\/496393\/","og_site_name":"Inc42 Media","article_publisher":"https:\/\/facebook.com\/Inc42","og_image":[{"width":1200,"height":628,"url":"https:\/\/inc42.com\/cdn-cgi\/image\/quality=75\/https:\/\/asset.inc42.com\/2025\/01\/Riceberg-funding-2-1.jpg","type":"image\/jpeg"}],"author":"Kartikay Kashyap","twitter_card":"summary_large_image","twitter_title":"Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr","twitter_description":"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.","twitter_creator":"@Inc42","twitter_site":"@Inc42","twitter_misc":{"Written by":"Kartikay Kashyap","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/#article","isPartOf":{"@id":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/"},"author":{"name":"Kartikay Kashyap","@id":"https:\/\/inc42.com\/#\/schema\/person\/6642e5258c341daf8346ad866f7c9e12"},"headline":"Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr","datePublished":"2025-01-23T09:13:27+00:00","dateModified":"2025-01-23T10:14:43+00:00","mainEntityOfPage":{"@id":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/"},"wordCount":385,"publisher":{"@id":"https:\/\/inc42.com\/#organization"},"image":{"@id":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/#primaryimage"},"thumbnailUrl":"https:\/\/inc42.com\/cdn-cgi\/image\/quality=75\/https:\/\/asset.inc42.com\/2025\/01\/Riceberg-funding-1.png","keywords":["Banking","Finance","Services","Spot News"],"articleSection":["News"],"inLanguage":"en","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/inc42.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/","url":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/","name":"Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr","isPartOf":{"@id":"https:\/\/inc42.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/#primaryimage"},"image":{"@id":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/#primaryimage"},"thumbnailUrl":"https:\/\/inc42.com\/cdn-cgi\/image\/quality=75\/https:\/\/asset.inc42.com\/2025\/01\/Riceberg-funding-1.png","datePublished":"2025-01-23T09:13:27+00:00","dateModified":"2025-01-23T10:14:43+00:00","description":"Kotak Alt, has made the first close of its life sciences fund at INR 250 Cr with a target corpus of INR 1,600 Cr.","breadcrumb":{"@id":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/#breadcrumb"},"inLanguage":"en","potentialAction":[{"@type":"ReadAction","target":["https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/"]}]},{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/#primaryimage","url":"https:\/\/inc42.com\/cdn-cgi\/image\/quality=75\/https:\/\/asset.inc42.com\/2025\/01\/Riceberg-funding-1.png","contentUrl":"https:\/\/inc42.com\/cdn-cgi\/image\/quality=75\/https:\/\/asset.inc42.com\/2025\/01\/Riceberg-funding-1.png","width":1360,"height":1020,"caption":"Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr"},{"@type":"BreadcrumbList","@id":"https:\/\/inc42.com\/buzz\/kotak-alt-marks-first-close-of-its-life-sciences-fund-at-inr-250-cr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/inc42.com\/"},{"@type":"ListItem","position":2,"name":"Kotak Alt Marks First Close Of Its Life Sciences Fund At INR 250 Cr"}]},{"@type":"WebSite","@id":"https:\/\/inc42.com\/#website","url":"https:\/\/inc42.com\/","name":"Inc42 Media","description":"India\u2019s #1 Startup Media & Intelligence Platform","publisher":{"@id":"https:\/\/inc42.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/inc42.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en"},{"@type":"Organization","@id":"https:\/\/inc42.com\/#organization","name":"Inc42 Media","url":"https:\/\/inc42.com\/","logo":{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/inc42.com\/#\/schema\/logo\/image\/","url":"https:\/\/inc42.com\/cdn-cgi\/image\/quality=75\/https:\/\/asset.inc42.com\/2017\/03\/inc42-amp-logo.png","contentUrl":"https:\/\/inc42.com\/cdn-cgi\/image\/quality=75\/https:\/\/asset.inc42.com\/2017\/03\/inc42-amp-logo.png","width":120,"height":36,"caption":"Inc42 Media"},"image":{"@id":"https:\/\/inc42.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/Inc42","https:\/\/x.com\/Inc42","https:\/\/www.instagram.com\/inc42.media\/","http:\/\/linkedin.com\/company\/inc42","https:\/\/www.youtube.com\/user\/inc42tv"],"description":"Inc42 is India\u2019s #1 startup media & intelligence platform that informs, educates and empowers startup & business leaders through its incisive reporting, insightful reports, curated events & communities, and industry-leading executive courses & programs. Since launching in January 2015, and having risen to become the authoritative voice on India\u2019s startup economy, we've moved markets, gotten the early scoop on billions of dollars of transactions and told you what's happening deep inside some of the fastest growing startups & industries alike. Our stories have been followed by the Wall Street Journal, Bloomberg, Reuters, TechCrunch and other major outlets hundreds of times. We also track over 50,000+ startups and provide market research and intelligence through our in-depth research reports, and we organise some of the most sought-after conferences and events for startup & business leaders across India. In 2020, we introduced Inc42 Plus, our exclusive membership program tailored for startup & business leaders, amassing over 10,000 members in record time. Apart from our sharp reporting & insightful research, through Inc42 BrandLabs, we partner with enterprises & brands to help them create branded content & experiences and reach our audience of decision makers.","legalName":"Ideope Media Private Limited","foundingDate":"2014-11-21","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"51","maxValue":"200"},"publishingPrinciples":"https:\/\/inc42.com\/ethics\/","ownershipFundingInfo":"https:\/\/inc42.com\/ethics\/","correctionsPolicy":"https:\/\/inc42.com\/ethics\/","ethicsPolicy":"https:\/\/inc42.com\/ethics\/"},{"@type":"Person","@id":"https:\/\/inc42.com\/#\/schema\/person\/6642e5258c341daf8346ad866f7c9e12","name":"Kartikay Kashyap","image":{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/inc42.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/715b763d87dab7eb7174149e076ba573?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/715b763d87dab7eb7174149e076ba573?s=96&d=mm&r=g","caption":"Kartikay Kashyap"},"url":"https:\/\/inc42.com\/author\/kartikay-kashyap\/"}]}},"featured_image_link":"https:\/\/inc42.com\/cdn-cgi\/image\/quality=75\/https:\/\/asset.inc42.com\/2025\/01\/Riceberg-funding-1.png","post_category":"News","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/inc42.com\/wp-json\/wp\/v2\/posts\/496393"}],"collection":[{"href":"https:\/\/inc42.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inc42.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inc42.com\/wp-json\/wp\/v2\/users\/116473"}],"replies":[{"embeddable":true,"href":"https:\/\/inc42.com\/wp-json\/wp\/v2\/comments?post=496393"}],"version-history":[{"count":2,"href":"https:\/\/inc42.com\/wp-json\/wp\/v2\/posts\/496393\/revisions"}],"predecessor-version":[{"id":496407,"href":"https:\/\/inc42.com\/wp-json\/wp\/v2\/posts\/496393\/revisions\/496407"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/inc42.com\/wp-json\/wp\/v2\/media\/496395"}],"wp:attachment":[{"href":"https:\/\/inc42.com\/wp-json\/wp\/v2\/media?parent=496393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inc42.com\/wp-json\/wp\/v2\/categories?post=496393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inc42.com\/wp-json\/wp\/v2\/tags?post=496393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}